Mdm2 and Mdm4 loss regulates distinct p53 activities

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Mutational inactivation of p53 is common in human tumors.
• Negative regulators like MDM2 and MDM4 can also inhibit p53 function.
• Mice lacking Mdm2 or Mdm4 show distinct p53-dependent phenotypes.

Purpose of the Study:

• To investigate the distinct roles of MDM2 and MDM4 in regulating p53.
• To explore the interaction between MDM2 and MDM4 in p53 pathway control.

Main Methods:

• Generated triple knockout mice (p53, Mdm2, Mdm4) and corresponding cell lines.
• Utilized temperature-sensitive p53 mutant (p53A135V) in mouse embryo fibroblasts.
• Assessed p53 stability and target gene activation under different genetic conditions.
• Administered MDM2 antagonist nutlin-3 to Mdm4-null cells.

Main Results:

• Triple knockout mice phenocopied p53-null mice, confirming MDM2 and MDM4 as key negative p53 regulators.
• p53 induced apoptosis in Mdm2-null cells and cell cycle arrest in Mdm4-null cells.
• Cells lacking both MDM2 and MDM4 exhibited apoptosis, similar to Mdm2-null cells.
• Nutlin-3 treatment induced cell death in Mdm4-null cells, indicating p53 stabilization triggers apoptosis.

Conclusions:

• MDM2 and MDM4 exhibit distinct regulatory functions over p53 activity.
• MDM2 primarily drives p53-mediated apoptosis, while MDM4 influences cell cycle arrest.
• Targeting MDM2 or MDM4 offers distinct therapeutic strategies for p53-related cancers.